Publisher
Springer International Publishing
Reference177 articles.
1. Abbasi SH, Hosseini F, Modabbernia A, Ashrafi M, Akhondzadeh S. Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study. J Affect Disord. 2012;141:308–14.
2. Ader R, Felten DL. Psychoneuroimmunology. San Diego/New York/Toronto: Academic Press; 1991.
3. Ahuja N, Carroll BT. Possible anti-catatonic effects of minocycline in patients with schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry. 2007;31:968–9.
4. Akhondzadeh S, Tabatabaee M, Amini H, Ahmadi Abhari SA, Abbasi SH, Behnam B. Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial. Schizophr Res. 2007;90:179–85.
5. Akhondzadeh S, Jafari S, Raisi F, Ghoreishi A. A clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Paper presented at the WPA Section on Immunology and psychiatry – psychoneuroimmunology training workshop, Seeon, Munich, 11–13 July 2008.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献